Reclaim Your Life, Relearn To Relive at Transformations Drug & Alcohol Treatment Center
April 9, 2015
Reclaim Your Life at Transformations Drug & Alcohol Treatment Center
The road to addiction recovery takes immense strength, courage, support and guidance. This special edition of The Balancing Act examines the many faces of additions as host Olga Villaverde speaks with recovering addicts; those who have hit rock bottom and come out the other side. Joining her on the set is Dr. Maureen Esposito, Executive Vice President of Clinical Services at Transformations Drug & Alcohol Treatment Center in Delray Beach, Florida. The show offers real solutions for those trying to reclaim their life.
The Transformations Treatment center program with residential community housing is a comprehensive addiction treatment and long term rehabilitation service for men and women suffering from drug and alcohol addiction. Rooms are private in a home-like setting at Transformations Treatment Center. The family-like environment creates a community that is nurturing, supportive and individualized especially important for the recovering patients who are making the transition to live and lead sober lives. Olga Villaverde learns first hand just how comprehensive the facility is as she visits the treatment center. Their unique holistic rehabilitation approach provides healing to the mind, body and spirit and combines with skilled therapists, individualized approaches to therapy, home like residences, and a safe and serene campus environment truly sets them apart from other treatment centers.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.